ROMIO, SILVANA ANTONIETTA
 Distribuzione geografica
Continente #
NA - Nord America 2.013
EU - Europa 1.320
AS - Asia 724
Continente sconosciuto - Info sul continente non disponibili 5
AF - Africa 2
SA - Sud America 1
Totale 4.065
Nazione #
US - Stati Uniti d'America 1.962
CN - Cina 419
IT - Italia 275
DE - Germania 256
SE - Svezia 230
IE - Irlanda 181
SG - Singapore 157
UA - Ucraina 134
RU - Federazione Russa 124
VN - Vietnam 70
HK - Hong Kong 52
CA - Canada 50
GB - Regno Unito 48
FI - Finlandia 40
FR - Francia 17
TR - Turchia 16
BE - Belgio 6
EU - Europa 4
IN - India 4
ID - Indonesia 3
ES - Italia 2
GR - Grecia 2
NG - Nigeria 2
PL - Polonia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
IR - Iran 1
JP - Giappone 1
MX - Messico 1
PH - Filippine 1
RO - Romania 1
Totale 4.065
Città #
Ann Arbor 366
Chandler 215
Woodbridge 214
Hangzhou 199
Dublin 175
Frankfurt am Main 162
Jacksonville 160
Singapore 131
Dearborn 105
Ashburn 92
Milan 68
Fairfield 66
Houston 63
New York 62
Princeton 60
Santa Clara 58
Hong Kong 52
Beijing 44
Dong Ket 42
Wilmington 42
Cambridge 37
Nanjing 36
Shanghai 30
Lachine 28
Seattle 25
Altamura 21
Rome 18
Falls Church 17
Lawrence 17
Shenyang 13
Hebei 12
Toronto 12
Andover 11
Boardman 11
Helsinki 11
Guangzhou 10
Jinan 10
Nanchang 10
Changsha 7
Tianjin 7
Washington 7
Bologna 6
Brussels 6
Norwalk 6
Padova 6
Los Angeles 5
Nürnberg 5
Ottawa 5
Parma 5
Saint Louis 5
San Diego 5
Zhengzhou 5
Cagliari 4
Ningbo 4
Bergamo 3
Boston 3
Chengdu 3
Genova 3
Grumo Appula 3
Hefei 3
Jakarta 3
Jiaxing 3
Lanzhou 3
Mountain View 3
Podenzana 3
Swansea 3
Turin 3
Villa Faraldi 3
Vittuone 3
Brescia 2
Dallas 2
Florence 2
Fremont 2
Genoa 2
Katsina 2
Latina 2
Leawood 2
Marino 2
Moncalvo 2
Montréal 2
Munich 2
Pedrengo 2
Prevalle 2
Stockholm 2
Taizhou 2
Torino 2
Trieste 2
Warsaw 2
Wuhan 2
Alcamo 1
Aversa 1
Belvedere Marittimo 1
Berlin 1
Bordeaux 1
Borgomasino 1
Brno 1
Busto Arsizio 1
Casoria 1
Castella 1
Chicago 1
Totale 2.889
Nome #
Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study 443
Modelli marginali strutturali per lo studio dell'effetto causale di fattori di rischio in presenza di confondenti tempo dipendenti 197
Multiple outcomes associated with the use of metformin and sulphonylureas in type 2 diabetes: a population-based cohort study in Italy 181
Identificazione dei casi di malattie respiratorie croniche nelle banche dati sanitarie della Regione Lombardia 156
Risk of acute myocardial infarction during use of individual NSAIDs: A nested case-control study from the SOS project 152
Utilizzo di antidepressivi e rischio di frattura. 150
Comparison of different methods for the calculation of duration of NSAIDs use using different databases in the SOS Project 137
Identificazione dei casi di BPCO nei database sanitari amministrativi: il progetto CRACK-CRD. 133
Population-based analysis of non-steroidal anti-inflammatory drug use among children in four European countries in the SOS project: What size of data platforms and which study designs do we need to assess safety issues? 133
Potential Bias when excluding concepts from terminologies with different granularity: an illustration in the SOS Project 132
La persistenza medica e l'uso di farmaci antipertensivi generici e brand. 131
Incidence Rates of Hospitalization for Heart Failure in Europe. A Comparison Between Different Data Sources in the SOS Project. 126
A UMLS-based approach for the homogeneous identification of events in seven European health databases: A contribution to the safety of NSAIDs (SOS) Project 126
Harmonisation of Outcome Estraction for Hearth Failure across Data Sources in the SAFEGUARD Project 125
A comparison of incidence rates of upper gastrointestinal complications estimated from different data sources in the safety of NSAIDs. 125
Use of non-steroidal anti-inflammatory drugs (NSAIDs) in Europe: The SOS Project. 124
Real-world data from the health decision maker perspective. what are we talking about? 122
Impatto e prognosi delle nuove ospedalizzazioni per scompenso cardiaco 122
Meta-analisi della letteratura sulla relazione tra esposizione a insulina glargine e rischio di tumore. 119
Modelli flessibili per stimare gli effetti cumulati nei farmaci. 118
Antidepressivi in gravidanza ed esiti neonatali. Studio retrospettivo a base di popolazione in Lombardia 115
A comparison of Incidence Rates of Stroke estimated from different Data Souces in the SOS Project. 114
Risk of upper gastrointestinal complications associated with use of individual non-steroidal anti-inflammatory drugs in the SOS Project. 114
NSAID use among children in Europe in the SOS Project 112
Should methods of correction for multiple comparisons be applied in pharmacovigilance? Reasoning around an investigation on safety of oral antidiabetic drugs 112
Use of non-steroidal anti-inflammatory drugs and heart failure risk in the safety of non-steroidal anti-inflammatory drugs (SOS) Project. 109
Introductive remarks on Causal Inference 108
Total Mortality Rates Across Multiple Databases: Benchmarking Results from a distributed Data Network - the SAFEGUARD Project. 106
Risk Models for predicting stroke and Upper Gastrointestinal Complications in NSAID Users: the SOS Project 92
Combining evidence from multiple electronic health care databases: performances of one-stage and two-stage meta-analysis in matched case-control studies 63
Infodemia: perché è necessaria una statistical literacy. La lezione della pandemia. 45
Bayesian networks for monitoring the gender gap 44
Totale 4.186
Categoria #
all - tutte 12.930
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.930


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020417 0 0 0 0 74 74 82 25 65 24 50 23
2020/2021367 62 12 30 35 22 7 32 15 32 36 9 75
2021/2022291 5 28 17 31 31 36 13 13 16 20 14 67
2022/2023767 71 228 96 60 49 115 13 39 57 8 18 13
2023/2024512 12 21 20 23 74 151 97 8 33 8 4 61
2024/2025428 64 116 106 41 101 0 0 0 0 0 0 0
Totale 4.186